0001587221-17-000016.txt : 20170525
0001587221-17-000016.hdr.sgml : 20170525
20170525204558
ACCESSION NUMBER: 0001587221-17-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170524
FILED AS OF DATE: 20170525
DATE AS OF CHANGE: 20170525
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zosano Pharma Corp
CENTRAL INDEX KEY: 0001587221
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454488360
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-1200
MAIL ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: ZP Holdings Inc
DATE OF NAME CHANGE: 20130919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WALKER JOHN PETER
CENTRAL INDEX KEY: 0001213529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36570
FILM NUMBER: 17871521
MAIL ADDRESS:
STREET 1: 126 ISABELLA AVE
CITY: ATHERTON
STATE: CA
ZIP: 94027
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-05-24
0001587221
Zosano Pharma Corp
ZSAN
0001213529
WALKER JOHN PETER
C/O ZOSANO PHARMA CORPORATION
34790 ARDENTECH COURT
FREMONT
CA
94555
1
1
0
0
Interim CEO
Common Stock
2017-05-24
4
P
0
36166
1.3425
A
169344
D
Common Stock
2017-05-25
4
P
0
37550
1.3672
A
206894
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
/s/ Jeffrey L. Quillen, attorney-in-fact
2017-05-25